MiMedx Group, Inc Common Stock MDXG
i
Market datapartial · fetched 2026-11-11T15:32:53.130Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T15:32:26.72097754Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-11T15:32:51.924362+00:00
MiMedx Group, Inc Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | 4.79 | 172.8% | 55.4% | |||
| 40Δ | 4.52 | 179.5% | 50.6% | |||
| 45Δ | 4.25 | 186.1% | 45.8% | |||
| 50Δ | 3.98 | 192.8% | 41.1% | |||
| 55Δ | 3.72 | 199.5% | 36.3% | |||
| 60Δ | 3.45 | 206.2% | 31.5% | |||
| 65Δ | 3.18 | 212.9% | 26.7% | |||
| 70Δ | 2.91 | 219.5% | 21.9% | |||
| 75Δ | 2.64 | 226.2% | 17.1% | |||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 4.79
- IV
- 172.8%
- B/E move
- 55.4%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 4.52
- IV
- 179.5%
- B/E move
- 50.6%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 4.25
- IV
- 186.1%
- B/E move
- 45.8%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 3.98
- IV
- 192.8%
- B/E move
- 41.1%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 3.72
- IV
- 199.5%
- B/E move
- 36.3%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 3.45
- IV
- 206.2%
- B/E move
- 31.5%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 3.18
- IV
- 212.9%
- B/E move
- 26.7%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 2.91
- IV
- 219.5%
- B/E move
- 21.9%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 2.64
- IV
- 226.2%
- B/E move
- 17.1%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Biotechnology
MESO
Mesoblast Limited, a biopharmaceutical company, develops and markets allogeneic cellular drugs. The company is headquartered in Melbourne, Australia.
More →MGNX
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapies to treat cancer in the United States. The company is headquartered in Rockville,…
More →MGTX
MeiraGTx Holdings plc, a clinical-stage gene therapy company, focused on developing treatments for patients living with serious illnesses. The company is headquartered in New…
More →MIRM
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver…
More →MIST
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular drugs. The company is headquartered in Montral,…
More →MLTX
Description unavailable
More →